MIRA INFORM REPORT
|
Report Date : |
20.05.2011 |
IDENTIFICATION DETAILS
|
Name : |
MEDIFARMA |
|
|
|
|
Registered Office : |
Ecuador 787, Cercado, Lima |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
24.01.1961 |
|
|
|
|
Com. Reg. No.: |
Entry No. 11012839 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture and commercialization of pharmaceuticals
for human use |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$1,050,000 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Peru |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
IDENTIFICATION
|
CORRECT
COMPANY NAME |
:
|
MEDIFARMA S.A. |
|
TRADE
NAME |
:
|
"MEDIFARMA" |
|
TAXPAYER
REGISTRATION |
:
|
RUC 20100018625 |
|
MAIN
ADDRESS |
:
|
Ecuador 787, Cercado |
|
CITY |
:
|
Lima |
|
DEPARTMENT/STATE |
:
|
Lima |
|
COUNTRY |
:
|
PERU |
|
TELEPHONE |
:
|
3326200 |
|
FAX |
:
|
4319764 |
|
WEB
SITE |
:
|
SUMMARY
INCORPORATION :
1961
LAST CAPITAL :
S/.68,027,387.= Nuevos Soles
SHAREHOLDERS ' EQUITY : S/.28,520,000.= New Sols
(31-12-2003)
SALES :
0.00
EMPLOYEES :
806
PAYMENTS :
Usually to terms/good
CHIEF EXECUTIVE :
GALVEZ DELGADO, IVAN
Disposition :
(They) refused to give information at all
(politely).
LEGAL
BACKGROUNDS
|
LEGAL
ESTATUS |
:
|
Joint-Stock Company |
|
DATE
OF INCORPORATION |
:
|
24JAN1961 |
|
START
OF OPERATIONS |
:
|
N/A |
|
REGISTERED
IN |
:
|
Lima |
|
NOTARY
OFFICE |
:
|
Jorge Eduardo Orihuela
Iberico |
|
DURATION |
:
|
Indefinite |
|
REGISTRATION |
:
|
Entry No. 11012839 |
|
INITIAL
CAPITAL |
:
|
N/A |
|
CURRENT
PAID-IN CAPITAL |
:
|
S/.68,027,387.= Nuevos Soles |
|
LAST
CAPITAL INCREASE |
:
|
03/11/2008 |
|
SHAREHOLDERS'
EQUITY |
:
|
S/.28,520,000.= New Sols
(31-12-2003) |
|
TYPE
OF SHARES |
:
|
Common |
|
LISTED
AT STOCK EXCHANGE |
:
|
No |
|
SHARE
VALUE |
:
|
S/.1.= Nuevo Sol |
|
CURRENT
EXCHANGE RATE |
:
|
S/.2.77 per US$1.00.= |
|
MEMBERSHIP |
:
|
N/A |
COMMENTS
.-
Latest capital increase dated 03/11/2008 was made
through capitalization of retained earnings.
HiSTORY
The history of Medifarma started with the creation of laboratories EFESA S.A.
on March 23, 1964, aimed at providing manufacturing and marketing services to
different international laboratories such as American Cyanamid Co., Atral,
Carter Wallace, Eli Lilly and Company, Gianfarma, Imperial Chemical Industries,
Wyeth Laboratories, Lederle, Merck Sharp & Dohme, Mycofarm, Norwich-Eaton
Pharmaceuticals, Pfizer, Schering Co., Smith Kline & French.Laboratories,
Spedrog and Synthelabo Pharma.
In April 1975, EFESA S.A expanded its activities under the name Laboratorios SA
Medifarma in order to compete directly in the national pharmaceutical market
with products of its own.
In August 1984, Drogueria Medifarma SA started
operating to include the conditioning and commercialization of pharmaceutical
products to be imported.
On March 7, 1996, Medifarma acquired its present
status through the merger of Drogueria
Medifarma SA and Laboratorio Medifarma
Medifarma SA finally consolidating all activities into a single name.
In 2005, MEDIFARMA SA started its expansion process
by acquiring the brands and production rights of the line of Dr. Zaidman.
In December 2006 MEDIFARMA SA acquired the 100% of
the shares and rights of TRIFARMA SA Laboratories.
In 2007 Medifarma through the following
initiatives, ventured into international markets:
Gaseovet entered the U.S. after it got FDA
approval.
The Mentholatum Company Medifarma designated
Medifarma manufacturer of its line of ointments for Latin America, serving as a
first stage the following countries: Chile, Panama, Guatemala and Nicaragua.
It acquired the 50% of Corporación Magma Ecuador,
introducing a line of branded pharmaceutical products in that country.
At present, MEDIFARMA SA manufactures a wide range
of ethical drugs, generics and consumer (OTC), being a leader in the Peruvian
pharmaceutical market, it also provides manufacturing, packaging and/or
conditioning services to companies such
as: GrĂ¼nenthal Peruana SA (Trifarma), The Mentholatum Company and Laboratorios
Pierre Fabre.
This is a 100% peruvian-capital pharmaceutical
company.
It was formed on
24/01/1961 under the name LABORATORIOS MEDIFARMA S.A.. Subsequently,
on 16/04/1975 it adopted the current
name: MEDIFARMA S.A.
Later, on 16.04.1975, it changed its name to :
MEDIFARMA SA.
Over the years, the Company merged the following
firms:
04.01.1982: MEDIFARMA MARCEUTICA SA
26.07.1994: FERREYCO SA, NORFESA SA, SURFESA SA,
DISELVA SA and CENTROFESA SA
01.03.1995: SPEDROG PERUANA SA
16.10.1995: LABORATORIOS FAPESA SA
13.03.1996: CONSTRUCTORA LOS OLIVOS SA
25.08.1997: COMERCIALIZADORA NACIONAL DE ABARROTES
SA.
All these enterprises were dissolved without being
liquidated.
Until April 2003, the Company shares were listed at
the Stock Exchange of Lima.
DIRECTORS
/ EXECUTIVES / SHAREHOLDERS
|
FULL
NAMES / COMPANY NAME |
TITLE |
OWNERSHIP
% |
|
PICASSO CANDAMO, FRANCISCO
JAVIER |
President |
|
|
PICASSO CANDAMO, JOSE MARTIN |
Vice President |
|
|
ANDRADE VILLAR, CARLOS
ALBERTO |
Director |
|
|
KANASHIRO CHINEN, LUIS
ALBERTO |
Technical Director |
|
|
GALVEZ DELGADO, IVAN |
General Manager |
|
|
SUCASAIRE CORNEJO, VICENTE
VICTOR |
Plant Manager |
|
|
APESTEGUI CASTRO, JUAN
GUALBERTO GABRIEL |
Operations Manager |
|
|
MORALES SALGUERO, CHANDY |
Commercial Manager |
|
|
HAYASHIDA HAYASHI, PATRICIA CARMEN |
Finance Manager |
|
|
HUAMAN HERRERA, SILVIA
MARIELLA |
General Accountant |
|
|
LABORATORIOS TRIFARMA S.A. |
Shareholder / Member |
0.01% |
|
CORPORACION AGROINDUSTRIAL
SAN JACINTO |
Parent Co. |
99.99% |
WHO
IS WHO?
PICASSO
CANDAMO, FRANCISCO JAVIER
NATIONALITY : Peruvian
BORN : 26DEC1961
DOC OF IDENT. : DNI 08256636
HOME ADDRESS : Los Robles 509, San Isidro, Lima,27
CIVIL STATUS : Married to Lucía Elejalde Franco
BACKGROUND INFORMATION .-
ATTORNEY'S GENERAL OFFICE:
According to the inquiries made into the of the Attorney
General's Office, Francisco Javier Picasso Candamo was found the following
criminal claims:
- Fraud. Before the 3rd District Attorney General
Office of Lima dated
09/06/2003,
Docket 2003-807 (with ruling).
Aggrieved
party: Migone Rivera de Harman María Jesús and Migone
Rivera de
Eschmann Ana Maria.
- Infringement of Labor Liberties before the 6th
District Criminal Attorney
General's
Office of Lima dated 12/01/2001.
Aggrieved
party: Morales Milla Evaristo Abelardo
- Fraud before the 19th District Criminal Attorney
General's Office of Lima
dated
25/08/1998 (pending report)
Aggrieved
party: Ñaupari de Rodriguez Marcelina Adela
Associated
as per our database to :
|
Company |
Position |
Tax.
Reg. |
Country |
|
LABORATORIOS TRIFARMA S.A. |
President |
20100061717 |
PERU |
|
P & D ANDINA ALIMENTOS
S.A. |
President |
20205922149 |
PERU |
|
CORPORACION AGRO INDUSTRIAL
PROGRESO S.A. |
General Manager |
20498957715 |
PERU |
Subject
is reported to participate or have participated in :
|
Company |
Position |
Country |
|
FABRICA DE PAPELES PARACAS
S,.A. |
President |
PERU |
|
BANCO WIESE LTDO. |
Director |
PERU |
|
HACIENDAS GANADERAS S.A. |
Director |
PERU |
|
CORP. AGRO INDUSTRIAS PROGRESO
S.A. |
Director |
PERU |
|
COMPAÑIA MINERA YAHUARCOCHA
S.A. |
Director |
PERU |
|
GATOSOL FINANCIAL CORP.,
SUC- |
Director |
PERU |
PICASSO
CANDAMO, JOSE MARTIN
NATIONALITY : Peruvian
DOC OF IDENT. : DNI 08272296
CIVIL STATUS : Married to Claudia Bentin Banchero
BACKGROUND INFORMATION .-
He takes part in the companies of PICASSO CANDAMO.
Associated
as per our database to :
|
Company |
Position |
Tax.
Reg. |
Country |
|
ESTANCIAS GANADERAS
ASOCIADAS S.A. |
Vice President |
20100089727 |
PERU |
|
SHERWIN WILLIAMS PERUANA
S.A. |
Vice President |
20100033853 |
PERU |
|
CORPORACION DE INVERSIONES
PROGRESO S.A. |
Vice President |
20268745301 |
PERU |
|
COMPAÑIA PERUANA DEL AZUCAR
SAC |
Vice President |
20381459242 |
PERU |
|
INTERNACIONAL DE PINTURAS
S.A. |
Vice President |
20345356127 |
PERU |
|
DIFESA DISTRIBUCIONES S.A. |
Director |
20100027535 |
PERU |
|
LABORATORIOS TRIFARMA S.A. |
Director |
20100061717 |
PERU |
KANASHIRO
CHINEN, LUIS ALBERTO
NATIONALITY : Peruvian
DOC OF IDENT. : DNI 07920732
BACKGROUND INFORMATION .-
He took Postgrade studies and seminars on
Validation, Quality Assurance in Pharmaceutical Plants, Drugs Quality
Assessment, Quality Assurance ISO 9000 and Human Motivation at the Universidad
Nacional Mayor de San Marcos - UNMSM, Pontificia Universidad Catolica del Peru
- PUCP; Universida del Pacifico, ESAN, INDECOPI, the Pharmaceutical Chemists
Association of Peru, Chemical Association of Peru and Industrial Development
Center of SNI.
Professor and Lecturer on Quality and Productivity
in the Pharmaceutical Industry in Conferences and Seminars.
He has over
22 years of experience in the pharmaceutical industry.
GALVEZ
DELGADO, IVAN
NATIONALITY : Peruvian
BORN : 08MAY1962
DOC OF IDENT. : DNI 08242363
TAX ID : 10082423635
PROFESSION : Economist
HOME ADDRESS : Av. Jacaranda 317-201, Urbanización Valle Hermoso, Surco , Lima,34
BACKGROUND INFORMATION .-
Master in Business Adminstration - ESAN
He takes part in some companies of PICASSO CANDAMO. He has more than 17 years of managerial
experience in the pharmaceutical industry in companies like ABEEFE S.A..
He holds the position of General Manager in
FARMACEUTICA ANDINA S.A. (Tax ID RUC 20205922149).
According to the 3rd. District Criminal Attorney
General's Office of Lima, he was filed for ilegal collusion crime dated
12/10/2001, Docket 2001-896 (with
ruling).
Aggrieved party: Ministry of Industry, Tourism,
Integration and International Trade Negotiations and the State.
As of 12/10/2009 he was found a trial before the
11th. District Attorney General's Office for the crime against life, body and
health (Report pending).
Aggrieved party:
Borgo Shoobridge Claudia Maria and Galvez Shoobridge Claudia Maria.
On 16/07/2009 he was sued before the 57th District
Criminal Attorney General's Office of Lima,dated 16/07/2009 because of
disobedience and resistance to the Official Order.
Aggrieved party The State.
Associated
as per our database to :
|
Company |
Position |
Tax.
Reg. |
Country |
|
LABORATORIOS TRIFARMA S.A. |
Director General |
20100061717 |
PERU |
HAYASHIDA
HAYASHI, PATRICIA CARMEN
NATIONALITY : Peruvian
BORN : 17OCT1964
DOC OF IDENT. : DNI 06603404
HUAMAN
HERRERA, SILVIA MARIELLA
NATIONALITY : Peruvian
BORN : 12FEB1973
DOC OF IDENT. : 09673483
RELATED
COMPANIES TO SUBJECT COMPANY OR TO MAJORITY SHAREHOLDER
The Company is part of the group PICASSO CANDAMO
which is a conglomerate of companies which include:
|
COMPANY NAME |
COUNTRY |
AX. REG. |
RELATION |
|
CORPORACION AGROINDUSTRIAL
SAN JACINTO |
PERU |
20498957715 |
Parent Co. |
|
CORPORACION DE INVERSIONES
PROGRESO S.A. |
PERU |
20268745301 |
Related |
|
LABORATORIOS TRIFARMA S.A. |
PERU |
20100061717 |
Shareholder / Member |
|
P & D ANDINA ALIMENTOS
S.A. |
PERU |
20205922149 |
Related |
BUSINESS
MAIN
ACTIVITY .-
Manufacture and commercialization of
pharmaceuticals for human use
Trademarks: ABBRONCOL, GASEOVET, MENTHOLATUM,
GRAVOL.
IMPORT : Yes
Argentina,
Austria, Brazil, Chile, China, Colombia, Czech Republic, Ecuador,
Finland,
France, Germany, Hungary, India, Israel, Italy, Japan, Korea...
Annual Imports in US$ (CIF) :
Year
Monto
2010 4,422,413.00
2009 11,064,581.00
2008 8,954,075.00
2007 5,162,940.00
2006 2,193,420.00
EXPORT : Yes
Chile,
Ecuador and Venezuela
Annual Exports in US$ (FOB) :
Year
Monto
2010 3,178,628.00
2009 901,327.00
2008 708,548.00
2007 226,002.00
2006 1,346.00
|
%
CASH SALES/METHOD |
:
|
N/A |
|
%
CREDIT SALES/TERMS |
:
|
100% (at 90, 120 and 150
days) |
|
%
FOREIGN SALES (COUNTRIES) |
:
|
N/A |
|
%
DOMESTIC PURCHASES |
:
|
40% |
|
%
FOREIGN PURCHASES |
:
|
Latest capital increase
dated 03/11/2008 was made through capitalization of retained earnings. |
|
SELLING
TERRITORY |
:
|
Domestic market - 100% |
|
EMPLOYEES |
:
|
806 |
LOCATION
.-
|
Premises |
:
|
Own |
|
Monthly
Amount |
:
|
N/A |
|
Time
Occupied |
:
|
N/A |
|
Area |
:
|
16,039.52 m2 |
|
Floors |
:
|
N/A |
|
Equipment |
:
|
N/A |
|
Condition |
:
|
Good |
|
Use |
:
|
Headquarters, production
plant |
Remarks and other Premises .-
Own premises, acquired through leasing.
The Company has other premises acquired through the
same modality. They are located at:
- Av. Santa Cecilia 230, Ate Vitarte, Lima.
- Av. Santa Rosa 390, Ate Vitarte, Lima (Plant).
The Company has two independent plants, modern
infrastructure and cutting-edge technology which allow to ensure the
manufacture of products of the highest quality, meet the international
standards to comply with the GMP set forth Dirección General de Medicamentos,
Insumos y Drogas - DIGEMID-Perú (General Administration of Medicines, Inputs
and Drugs)and other Government entities of the health sector in Argentina,
Colombia and United States.
PLANT - LIMA:
This plant covers an area of 20,000 m2 and a built area of 13,500 m2 to
accommodate two independent sub-plants:
For non-beta lactam products, 12,700 m2 and for beta lactam products,
800 m2. Each manufacturing area has
independent personnel, services and supplies in order to avoud any
contamination and meet the GMP established by DIGEMID-Peru.
PLANT - ATE: This plant was acquired through the
acquisition of TRIFARMA. It covers a built area of 18,000 m2 and two
independent areas, distributed as follows:
For non-beta lactam products, 17,000 m2 and for beta lactam and
penicillin products, 1,000 m2. Just like
in Lima Plant, each manufacturing plant is independent to avoid contamination.
COMMENTS .-
The Company also imports from Mexico, Switzerland,
Sweden, Singapore, Spain, Taiwan, United Kingdom and United States.
Until June 1998, commercialization was carried out
directly (own distributor). That same
year in July, distribution started to be made through third-party.
Main Clients: Distributors and public entities,
among them:
- MINISTERIO DE SALUD (Ministry of Health)
- ESSALUD (National Institute of Social Security)
- Hospitales
- Police Force
- Military hospitals
- SISTEMA METROPOLITANO DE LA SOLIDARIDAD
(specialized and complete health program)
In 2008, MEDIFARMA SA ranked the 2nd position
because of a variety of formulations and presentations which accounted for an
annual volume of 49,431,637 units.
Just in 2008, prices offered by MEDIFARMA S.A.
allowed the State to save more than S/.4,000,000.00.
FINANCIAL
INFORMATION
|
Interviewee(s) |
:
|
Silvia Huaman Herrera |
|
Position(s) |
:
|
General Accountant |
|
Cooperation |
:
|
(They) refused to give
information at all (politely). |
|
Information
Provided |
:
|
We contacted Silvia Huaman
Herrera who refused to give information even though we revealed the name of
the supplier inquiring this report. In
view of our insistence, we contacted Elizabeth Kobashicaura who told us the
General Manager as instructed by the President, ordered her not to provide
any information about the Company. For
this reason, this report has had to be prepared based on the information
collected from outside sources where no balance sheets or estimated
accounting figures were available. |
FINANCIAL
SITUATION : Active
Financial situation is indeterminate since no
accounting elements were available to assess this Company current results.
Found out turnover for the Fiscal Year 2008 (latest
figure available) came to S/.178,024,800.= Nuevos Soles.
MEDIFARMA S.A. ranks the 5-top position among the
pharmaceutical laboratories in Peru and ranks first position in sales as a
laboratory of national capital.
Products of its own are leaders in different therapeutical classes and
has been authorized by more than 100 brands to be traded in pharmacies,
drugstores, and Government entities, to serve demand of different
pharmaceutical specialties.
PROPERTY
OF THE COMPANY .-
REAL ESTATES:
- Av. Industrial 741, Lima 1
- Jr. Ecuador 787, Lima 1
- Av. Santa Rosa 390, Ate Vitarte, Lima 3
- Santa Cecilia 230, Ate Vitarte, Lima 3
.
INSURANCE
.-
|
Company |
Againts |
Amount |
Expiration |
|
RIMAC INTERNACIONAL CIA. DE
SEGUROS |
All risk |
US$.68,000,000.= |
N/A |
PAYMENTS
RECORD
TRADE REFERENCES .-
|
Supplier |
Country |
Tel. |
Line of Credit |
Monthly Average |
Terms(days) |
Perfomance? |
Time |
Products/Services |
|
Amfa Vitrum S.A. |
PERU |
(511) 5710310 |
UNLIMITED |
US$ 25,000.= |
45 days |
Prompt |
5 years |
Products for the
pharmaceutical industry |
|
Servicios Gráficos Callao
S.A. |
PERU |
(511) 5781928 |
UNLIMITED |
US$ 20,000 /30,000.= |
Inv./30 days |
Prompt |
12 years |
Boxes for medicines |
|
Negociar S.A. |
PERU |
(511) 3490269 |
UNLIMITED |
US$ 20,000.= |
30 days |
Prompt |
15 years |
Chemicals |
|
Asiaduanas S.A. |
PERU |
(511) 6147200 |
N/A |
Variable |
CASH |
No experience |
4 years |
Customs services |
|
Drocersa |
PERU |
(511) 4715495 |
US$ 230,000.= |
N/A |
Draft/30 days |
Prompt |
2002 |
Chemical inputs |
|
Compañía Minera Lincuna
S.A.C. |
PERU |
(511) 2611111 |
UNLIMITED |
US$ 100,000.= |
30,45 days |
Prompt |
3 years |
Medicines |
NOTE: Other Suppliers did not
provide information or could not be consulted.
|
Supplier |
Country |
Tel. |
|
Borealis AG. |
AUSTRIA |
N/A |
|
Helvoet Pharma Italia S.R.L. |
ITALY |
N/A |
|
West Pharmaceutical Services |
COLOMBIA |
N/A |
|
Papelera del Sur S.A. |
PERU |
(511) 6142626 |
|
Andenex Chemie Engelhard |
GERMANY |
N/A |
|
Basell Sales & Marketing
Company BV |
NETHERLANDS |
N/A |
|
Ferro IM UND Export GMBH |
GERMANY |
N/A |
|
Polipropileno del Caribe
S.A. |
COLOMBIA |
N/A |
|
DVA Health & Nutrition
GMBH |
GERMANY |
N/A |
|
Selectchemie AG. |
GERMANY |
|
|
Aduamerica S.A. |
PERU |
(511) 6255000 |
|
Givaudan Argentina S.A. |
ARGENTINA |
(5411) 47629000 |
COMMENTS .-
One of the suppliers only commented to have done
business with the Company for 5 years. It is considered a good client. It buys
products in general. No negative records found.
CREDIT RISK CENTRAL .-
Found out a total of 10 protested documents (unpaid
on the maturity debt). Only one of them has not been paid.
These protest were:
2009: 4 protests for the sum of US$80,605.= Dollars
2008: 6 protests for the sun of US$745,466.=
Dollars
LAWSUITS .-
No civil or criminal
proceedings have been filed against this Company.
BANKING
INFORMATION
BANKERS
.-
|
Bank |
Contact |
Telephone |
Account # |
DC (S/.) |
FC (US$) |
|
BANCO INTERBANK |
N/A |
N/A |
N/A |
N/A |
N/A |
|
BBVA BANCO CONTINENTAL |
N/A |
N/A |
N/A |
N/A |
N/A |
|
INTERAMERICANO DE FINANZAS |
N/A |
N/A |
N/A |
N/A |
N/A |
The Company is a client of the above banks. Further
information was not given under bank secrecy.
SUPERINTENDENCY
OF BANK & INSURANCE.-
The SBS reported the following debts the Financial
System as at 30NOV2010 (Last Report)
|
Obligations |
DC (S/.) |
FC (US$) |
|
Advance in current account cont |
0.00 |
0.00 |
|
Advance in current account cont |
5,019.00 |
0.00 |
|
Credit Cards-Contract |
0.00 |
0.00 |
|
Overdrafts-Current Account |
0.00 |
0.00 |
|
Discounts-Drafts |
55,456,803.00 |
0.00 |
|
Discounts promissory note |
0.00 |
0.00 |
|
Loans |
55,970,070.00 |
0.00 |
|
Financial Leasing |
46,662,579.00 |
0.00 |
|
Foreign trade credit |
24,483,540.00 |
0.00 |
|
Current accruals |
486,055.00 |
0.00 |
|
Letters of indemnity |
0.00 |
0.00 |
|
Letters of credit |
0.00 |
0.00 |
|
Banking acceptance |
0.00 |
0.00 |
|
other OTROS 1 INGLES |
29,047,658.00 |
0.00 |
|
: Indirect debt |
|
|
|
Total Indebtedness |
212,111,724.00 |
0.00 |
|
Guarantees |
134,362,807.00 |
0.00 |
Debt structure for Bank
(Domestic Currency)
|
|
RATING |
% |
RATING DESCRIPTION ACCORDING
TO THE SBS |
|
X |
NORMAL |
100 |
Good Financial Situation.
Prompt payments, Consitent and Updated Information. |
|
|
PROBLEM POTENTIAL |
- |
Satisfactory Financial
Situation but cash flow can weaken which causes payment defaults. Irregular
trend. Weaken which causes payment defaults. Irregular trend. |
|
|
DEFICIENT |
- |
Deficient Financial Situation
with cash problems, profis shortage, continuous delayed payments, overdue
credits and/or collection by count order, decreasing trend. |
|
|
DOUBTFUL |
- |
Heavy Financial Situation,
cash flow shortage, continuous delayed payments, overdue credits and/or
collection by court order. Not too reliable information. Bad management. |
|
|
LOSS |
- |
Bad Financial Situation,
cash flow does not cover production costs, declared bankruptcy, payment
discontinuance,collection by court order. Bad management. |
Debt structure for Bank
(Domestic Currency)
|
Bank |
Amoun (S/.) |
|
BANCO SANTANDER PERU |
26,725,997.00 |
|
BBVA BANCO CONTINENTAL |
72,226,709.00 |
|
BANCO INTERBANK |
66,092,810.00 |
|
BANCO INTERAMERICANO DE
FINANZAS |
36,110,121.00 |
|
BANCO DE COMERCIO |
5,612,596.00 |
|
BANCO FINANCIERO |
836,438.00 |
|
FINANCIERA AMERIKA |
3,872,686.00 |
|
AMERICA FACTORING |
634,368.00 |
CREDIT
OPINION
This Company may
be granted a credit limit amounting to US$1,050,000.= Dollars.
NOTE: The Opinion given is confidential referential
and with out liability
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.98 |
|
|
1 |
Rs.72.68 |
|
Euro |
1 |
Rs.64.16 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market
trend (10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.